VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AVAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AVAHAveanna Healthcare Holdings Inc.
$12.59$2.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAVAHCash Flow

Aveanna Healthcare Holdings Inc. (AVAH) Cash Flow Statement

8Y historyFree accessUpdated daily

Free cash flow generation has been volatile, swinging from a negative $13.3M in 2024Q1 to a positive $79.6M in 2026Q2, with working capital changes being the primary driver of quarterly cash flow variability.

Income StatementBalance SheetCash FlowRatios

AVAH Cash Flow Statement

Annual statement

AVAH Cash Flow Statement

Aveanna Healthcare Holdings Inc. (AVAH) cash flow statement — 8-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMJan'26Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Cash from Operations168.2M122.24M32.64M22.67M-48.4M-11.35M116.62M-8.71M21.6M
Operating CF Margin %-5.02%1.61%1.2%-2.71%-0.68%7.8%-0.63%1.72%
Operating CF Growth %491.14%274.54%43.95%146.84%-326.45%-109.73%1438.28%-140.35%-
Net Income274.76M225.03M-10.93M-134.52M-662.03M-117.04M-57.05M-76.52M-47.15M
Depreciation & Amortization-2.43M28.22M31.16M30.1M38.82M35.39M30.22M27.01M11.94M
Stock-Based Compensation-12.01M017.46M13.16M15.89M14.43M3.27M1.95M2.12M
Deferred Taxes-607K-143.03M1.03M1.01M-115K1.31M-6.42M-919K-3.63M
Other Non-Cash Items-111.74M64.67M23.87M136.32M601.26M125.89M90.06M26.7M23.56M
Working Capital Changes20.22M-52.66M-29.97M-23.4M-42.22M-71.33M56.54M13.06M34.76M
Change in Receivables18.21M-30.22M-28.64M-15.32M-3.23M-8.81M8.56M3.34M-7.96M
Change in Inventory00000-27.06M0-13.2M15.4M
Change in Payables-5.65M-6.23M6.45M-13.92M-3.92M-11.7M-6.81M19.29M21.51M
Cash from Investing-183.89M-22.3M-6.32M-8.79M-25.29M-681.83M-193.54M-17.82M-229.55M
Capital Expenditures-2.37M-7.45M-6.32M-6.12M-12.01M-15.95M-15.24M-16.64M-19.58M
CapEx % of Revenue0.09%0.31%0.31%0.32%0.67%0.95%1.02%1.2%1.56%
Acquisitions-154.59M-14.85M00-1.55M-666.91M-178.31M-1.19M-209.97M
Investments---------
Other Investing-26.93M00-2.68M-11.27M0000
Cash from Financing12.15M9.03M14.03M10.85M62.42M586.33M210.94M21.86M204.15M
Debt Issued (Net)413K-3.76M-2.36M-5.73M60.15M161.59M136.69M68.94M149.73M
Equity Issued (Net)3.09M6.52M3.09M945K4.01M477.69M50M054.42M
Dividends Paid000000000
Share Repurchases4.62M00000000
Other Financing8.65M6.27M13.3M15.63M-1.74M-52.95M24.25M-47.07M0
Net Change in Cash-3.54M108.97M40.35M24.73M-11.27M-106.86M134.02M-4.67M-3.8M
Free Cash Flow165.83M114.79M26.32M16.56M-60.41M-27.3M101.38M-25.35M2.02M
FCF Margin %6.37%4.72%1.3%0.87%-3.38%-1.63%6.78%-1.83%0.16%
FCF Growth %111.2%336.17%58.96%127.4%-121.3%-126.93%499.91%-1356.87%-
FCF per Share0.740.530.140.09-0.33-0.150.55-0.140.01
FCF Conversion (FCF/Net Income)0.60x0.54x-2.99x-0.17x0.07x0.10x-2.04x0.11x-0.46x
Interest Paid-34.28M0152.51M137.85M102.53M58.96M73.05M92.81M62.77M
Taxes Paid005.71M1.14M1.59M5.28M2.17M1.55M3.15M

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Leverage and cash flow volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Earnings Quality Masked by Working Capital Swings

The relationship between net income and operating cash flow is highly erratic, with the OCF/NI ratio swinging from -1.66 to 2.36 over the past ten quarters, indicating that reported earnings are a poor proxy for underlying cash generation.

The wide dispersion in the OCF/NI ratio suggests that non-cash items and, more importantly, volatile working capital movements are the primary drivers of reported cash flow. For instance, in 2026Q1, a $41.7M net income translated to just $4.3M in operating cash flow due to a $50.7M working capital outflow, while in 2025Q3, a $14.1M net income generated $33.2M in cash. This pattern implies that the timing of Medicaid reimbursements and payables management create significant quarterly noise, obscuring the true cash conversion quality of the core business.

FCF Volatility Undermines Growth Narrative

Free cash flow has been inconsistent, ranging from a negative $13.3M in 2024Q1 to a positive $79.6M in 2026Q2, with the FCF margin fluctuating between -2.7% and 11.9%, demonstrating that top-line growth has not yet translated into a stable cash generation profile.

The FCF trajectory is heavily influenced by the aforementioned working capital volatility rather than consistent operational improvement. While the recent 11.9% FCF margin in 2026Q2 is encouraging, it follows a quarter with negative FCF, making it difficult to ascertain if this represents a new sustainable level. The disconnect between accelerating revenue growth and lumpy free cash flow suggests that the company's expansion may be consuming cash through working capital needs faster than it can generate it from operations.

Working Capital as the Primary Cash Flow Driver

Working capital changes have been the dominant factor in quarterly cash flow, with swings from a $50.7M use of cash in 2026Q1 to a $48.1M source in 2025Q4, indicating that the revenue cycle and payables management are more critical to near-term liquidity than profitability.

The magnitude of these working capital movements, often exceeding net income, points to a business where the efficiency of collecting from government payers and managing vendor payments dictates cash availability. The large negative swings, such as the $45.8M outflow in 2025Q1, may indicate periods of delayed reimbursements or strategic payables management, while large inflows suggest catch-up payments. This dynamic creates a cash flow profile that is inherently unpredictable on a quarterly basis, requiring investors to focus on trailing twelve-month trends rather than single-period results.

Acquisition-Fueled Growth Consumes Cash

Capital deployment has been dominated by acquisition activity, with a net $169.4M outflow in 2026Q2 alone, which appears to be the primary use of the company's operating cash flow and a key reason for its strained balance sheet.

The company's strategy of using cash for acquisitions, as seen in the $169.4M outflow in 2026Q2 and smaller amounts in other quarters, directly competes with debt reduction or shareholder returns. There is no evidence of dividend payments or share repurchases, indicating that all available cash is being reinvested into growth. This aggressive deployment, while driving the reported revenue acceleration, has likely contributed to the elevated leverage profile and leaves little buffer for operational shortfalls or debt service.

Cash Flow Statement Obscures True Leverage

The cash flow statement does not fully capture the company's financial risk, as the significant acquisition activity and volatile working capital mask the underlying cash burn required to service what appears to be a heavy debt load.

While the company reported positive operating cash flow in most quarters, the need to fund large acquisitions suggests that free cash flow after growth investments is minimal or negative. The absence of explicit debt repayment cash flows in the data, combined with the reported high debt/equity ratio, implies that the company may be relying on refinancing or credit facilities to manage its obligations. Furthermore, the stock-based compensation, which peaked at $11.0M in 2025Q1, is a non-cash expense that inflates operating cash flow relative to net income, a nuance that should be considered when assessing true cash earnings.

AVAH — Frequently Asked Questions

Quick answers to the most common questions about buying AVAH stock.

How much cash does Aveanna Healthcare Holdings Inc. (AVAH) generate from operations?

Aveanna Healthcare Holdings Inc. (AVAH) generated $122.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Aveanna Healthcare Holdings Inc.'s free cash flow?

Aveanna Healthcare Holdings Inc. (AVAH) generated $114.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Aveanna Healthcare Holdings Inc.'s capital expenditure (CapEx)?

Aveanna Healthcare Holdings Inc. (AVAH) spent $7.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.